Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: meta-analysis
- 1 November 2019
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in European Journal of Gastroenterology & Hepatology
- Vol. 31 (11), 1306-1312
- https://doi.org/10.1097/meg.0000000000001509
Abstract
Colonoscopy is the standard medical procedure to identify inflammatory bowel disease (IBD) in patients with gastrointestinal symptoms. Noninvasive measurement of faecal calprotectin concentration may replace colonoscopy in this indication. The study aimed to assess efficacy of faecal calprotectin as a diagnostic marker of IBD in patients with symptoms suggestive of such diagnosis. Meta-analysis of diagnostic accuracy studies was performed. Cochrane, EMBASE and MEDLINE databases were searched until December 2018. Inclusion criteria comprised experimental and observational studies, adults with gastrointestinal symptoms, calprotectin as index and colonoscopy as reference test, presence of data on/enabling the calculation of diagnostic accuracy parameters. For each study, sensitivity and specificity of faecal calprotectin were analysed as bivariate data. Nineteen studies were identified. The total number of patients was 5032. Calculated pooled sensitivity and specificity were 0.882 [95% confidence interval (CI), 0.827–0.921] and 0.799 (95% CI, 0.693–0.875), respectively. Following faecal calprotectin incorporation in the diagnostic work-up of 100 people with suspected IBD, 18 non-IBD patients will have a colonoscopy performed and one patient with the disease will not be referred for this examination. Faecal calprotectin concentration measurement is a useful screening test to rule out IBD, at the same time reducing the need for colonoscopy by 66.7%.Keywords
This publication has 40 references indexed in Scilit:
- Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary careScandinavian Journal of Gastroenterology, 2013
- Diagnostic Accuracy of Point-of-Care Fecal Calprotectin and Immunochemical Occult Blood Tests for Diagnosis of Organic Bowel Disease in Primary Care: The Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) StudyClinical Chemistry, 2012
- Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseasesInternational Journal of Colorectal Disease, 2008
- Accuracy of Four Fecal Assays in the Diagnosis of ColitisDiseases of the Colon & Rectum, 2007
- Prospective evaluation of faecal neutrophil‐derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectinAlimentary Pharmacology & Therapeutics, 2007
- Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic diseaseInternational Journal of Colorectal Disease, 2006
- Laboratory markers in IBD: useful, magic, or unnecessary toys?Gut, 2006
- Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificityEuropean Journal of Gastroenterology & Hepatology, 2003
- A simple method for assessing intestinal inflammation in Crohn's diseaseGut, 2000
- High prevalence of NSAID enteropathy as shown by a simple faecal testGut, 1999